- Home
- KFS vs ZVRA Comparison
KFS vs ZVRA Comparison
Compare KFS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFS
- ZVRA
- Stock Information
- Founded
- KFS 1989
- ZVRA 2006
- Country
- KFS United States
- ZVRA United States
- Employees
- KFS N/A
- ZVRA N/A
- Industry
- KFS Property-Casualty Insurers
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- KFS Finance
- ZVRA Health Care
- Exchange
- KFS Nasdaq
- ZVRA Nasdaq
- Market Cap
- KFS 437.4M
- ZVRA 467.6M
- IPO Year
- KFS 1996
- ZVRA 2015
- Fundamental
- Price
- KFS $13.24
- ZVRA $8.81
- Analyst Decision
- KFS
- ZVRA Strong Buy
- Analyst Count
- KFS 0
- ZVRA 7
- Target Price
- KFS N/A
- ZVRA $21.71
- AVG Volume (30 Days)
- KFS 76.9K
- ZVRA 1.6M
- Earning Date
- KFS 11-06-2025
- ZVRA 11-05-2025
- Dividend Yield
- KFS N/A
- ZVRA N/A
- EPS Growth
- KFS N/A
- ZVRA N/A
- EPS
- KFS N/A
- ZVRA 0.54
- Revenue
- KFS $128,567,000.00
- ZVRA $84,388,000.00
- Revenue This Year
- KFS N/A
- ZVRA $336.43
- Revenue Next Year
- KFS N/A
- ZVRA $54.26
- P/E Ratio
- KFS N/A
- ZVRA $16.39
- Revenue Growth
- KFS 18.31
- ZVRA 244.60
- 52 Week Low
- KFS $7.06
- ZVRA $6.19
- 52 Week High
- KFS $16.80
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- KFS 35.11
- ZVRA 35.32
- Support Level
- KFS $13.82
- ZVRA $9.67
- Resistance Level
- KFS $14.94
- ZVRA $10.56
- Average True Range (ATR)
- KFS 0.58
- ZVRA 0.55
- MACD
- KFS -0.11
- ZVRA -0.25
- Stochastic Oscillator
- KFS 23.79
- ZVRA 6.51
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.